Abstract
Breast cancer is one of the most common malignancies affecting women; thus, much effort has been put into understanding the genetics of predisposition to breast cancer as well as identifying factors involved in tumor progression and cancer prognosis. Conventional genetics was used to map and clone the two breast / ovarian cancer predisposition genes, BRCA1 and BRCA2. However, the vast majority of breast cancer cases are of a sporadic nature, likely due to a combination of environmental and genetic factors. Other genes have been identified via the analysis of protein interactions, screens based on inverse genomics, yeast two-hybrid assays, far Westerns, GST-pull downs and chromatography / mass spectrometry have been used to identify a number of proteins that interact with BRCA1 or BRCA2. Biological characteristics such as expression levels, protein stability and phosphorylation as well as the biological roles of the BRCA proteins in DNA repair and transcription have also led to the identification of o ther proteins involved in breast cancer. Recent advances in microarray analysis have allowed the identification of further genetic factors by comparing the transcription profiles of cell lines with varying levels of BRCA1 expression or drug resistance and tumors from patientswith or without BRCA1 / 2 mutations or with different pathobiological types of tumors or prognoses. Additionally, microarray analysis at the DNA level allows for the identification of genes that have been amplified or deleted during cancer progression, and tumor tissue arrays can be used to analyze hundreds of samples simultaneously for the expression of previously identified genetic factors.
Current Genomics
Title: Recent Advances in the Identification of Genetic and Biochemical Components of Breast Cancer Predisposition
Volume: 3 Issue: 5
Author(s): M. K. Sauer
Affiliation:
Abstract: Breast cancer is one of the most common malignancies affecting women; thus, much effort has been put into understanding the genetics of predisposition to breast cancer as well as identifying factors involved in tumor progression and cancer prognosis. Conventional genetics was used to map and clone the two breast / ovarian cancer predisposition genes, BRCA1 and BRCA2. However, the vast majority of breast cancer cases are of a sporadic nature, likely due to a combination of environmental and genetic factors. Other genes have been identified via the analysis of protein interactions, screens based on inverse genomics, yeast two-hybrid assays, far Westerns, GST-pull downs and chromatography / mass spectrometry have been used to identify a number of proteins that interact with BRCA1 or BRCA2. Biological characteristics such as expression levels, protein stability and phosphorylation as well as the biological roles of the BRCA proteins in DNA repair and transcription have also led to the identification of o ther proteins involved in breast cancer. Recent advances in microarray analysis have allowed the identification of further genetic factors by comparing the transcription profiles of cell lines with varying levels of BRCA1 expression or drug resistance and tumors from patientswith or without BRCA1 / 2 mutations or with different pathobiological types of tumors or prognoses. Additionally, microarray analysis at the DNA level allows for the identification of genes that have been amplified or deleted during cancer progression, and tumor tissue arrays can be used to analyze hundreds of samples simultaneously for the expression of previously identified genetic factors.
Export Options
About this article
Cite this article as:
Sauer K. M., Recent Advances in the Identification of Genetic and Biochemical Components of Breast Cancer Predisposition, Current Genomics 2002; 3 (5) . https://dx.doi.org/10.2174/1389202023350264
DOI https://dx.doi.org/10.2174/1389202023350264 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Unveiling Cancer in IBD: Screening Colonoscopy or Chromoendoscopy
Current Drug Targets How Do Microtubule-Targeted Drugs Work? An Overview
Current Cancer Drug Targets Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends
Current Drug Targets Biologic and Novel Therapy of the Inflammatory Bowel Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease
Current Drug Targets The Evolution of Clostridium difficile Infection in Cancer Patients: Epidemiology, Pathophysiology, and Guidelines for Prevention and Management
Recent Patents on Anti-Infective Drug Discovery Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Current Pharmaceutical Design Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases
Current Drug Targets Marine Depsipeptides as Promising Pharmacotherapeutic Agents
Current Protein & Peptide Science Towards Isozyme-Selective HDAC Inhibitors For Interrogating Disease
Current Topics in Medicinal Chemistry Anti Tumor Necrosis Factor Alpha (TNFα) Therapy in Ankylosing Spondylitis - Asian Perspective
Current Rheumatology Reviews Genetic Control of Sister Chromatid Recombination: The Role of Radiation Repair (RAD) Genes
Current Genomics Embryonic Stem Cell MicroRNAs: Defining Factors in Induced Pluripotent (iPS) and Cancer (CSC) Stem Cells?
Current Stem Cell Research & Therapy Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics
Current Clinical Pharmacology A Comprehensive Study of Pharmacological Behaviors, Nano-Formulations, and Applications of Rosemary
The Natural Products Journal Thromboprophylaxis in Medical Patients: An Update
Vascular Disease Prevention (Discontinued) Development of Doxorubicin Quantification by Reductive Amination
Current Analytical Chemistry Nitric Oxide, Peroxynitrite, Peroxynitrous Acid, Nitroxyl, Nitrogen Dioxide, Nitrous Oxide: Biochemical Mechanisms and Bioaction
Current Bioactive Compounds State of the Art of Biochemical Markers in Metastatic Bone Disease and the Role of Bisphosphonates as Therapeutic Agents
Current Pharmaceutical Analysis